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Abstract 
Store and forward telemedicine in resource-limited settings is becoming a relatively mature 
activity.  However, there are few published reports about quality measurement in 
telemedicine, except in image-based specialities, and they mainly relate to high- and middle-
income countries.  In 2010, Médecins Sans Frontières (MSF) began to use a store-and-
forward telemedicine network to assist its field staff in obtaining specialist advice.  To date, 
more than 1000 cases have been managed with the support of telemedicine, from a total of 40 
different countries.  We propose a method for assessing the overall quality of the 
teleconsultations provided in a store-and-forward telemedicine network.  The assessment is 
performed at regular intervals by a panel of observers, who -- independently -- respond to a 
questionnaire relating to a randomly-chosen past case.  The answers to the questionnaire 
allow two different dimensions of quality to be assessed:  the quality of the process itself and 
the outcome, defined as the value of the response to three of the four parties concerned, i.e. 
the patient, the referring doctor and the organisation.  It is not practicable to estimate the value 
to society by this technique.  The feasibility of the method was demonstrated by using it in the 
MSF telemedicine network, where process-quality scores, and user-value scores, appeared to 
be stable over a nine-month trial period.  This was confirmed by plotting the cusum of a 
portmanteau statistic (the sum of the four scores) over the study period.  The proposed quality 
assessment method appears feasible in practice, and will form one element of a quality 
assurance programme for MSF's telemedicine network in future.  The method is a generally 
applicable one, which can be used in many forms of medical interaction. 
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Introduction 
Médecins Sans Frontières (MSF) is a non-governmental humanitarian medical organisation 
that responds to emergency situations and provides medical assistance to those in need.  MSF 
teams provide medical emergency aid in difficult settings around the world, and staff often 
have to diagnose and treat patients with limited resources.[1]  In 2010, MSF began to use a 
store-and-forward telemedicine network to assist its field staff in obtaining specialist 
advice.[2]  To date, more than 1000 cases have been managed with the support of 
telemedicine, from a total of 40 different countries. 
 
In a store-and-forward telemedicine network of this type, doctors in the field refer cases 
electronically to obtain a second opinion about diagnosis or management.  Incoming cases are 
reviewed by a case coordinator and assigned for reply to one or more appropriate experts.  
The network therefore operates in a similar way to a bulletin board, with messages being 
posted by its users.  Although formal evidence for the clinical effectiveness of the 
telemedicine advice obtained through networks of this kind is rather scarce[3,4], they are 
known to provide a useful service to referring doctors, and several networks have operated for 
periods of more than a decade. 
 
Quality problem 
Since store and forward telemedicine in resource-limited settings is becoming a relatively 
mature activity, there is a concomitant requirement to implement quality 
assurance/improvement activities.  Indeed, it may be considered unethical not to do so.  
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However, there are few published reports about quality measurement in telemedicine, except 
in networks concerned with radiology[5], ophthalmology[6] or histopathology,[7] many of 
which are retrospective studies.  These reports concern image-based activities, which perhaps 
lend themselves more readily to quality measurement.  The situation in teleconsulting is more 
complex, being inherently multi-specialty in nature and one where there is often limited 
knowledge of outcomes.  Attempting to measure quality in such a context is more like 
attempting to measure overall quality in a multi-clinic outpatient department.  As far as we are 
aware, there have been no previous studies of prospective quality measurement in general 
teleconsulting work in low income countries. 
 
Objectives 
The primary Research Question was whether a method could be developed for quality 
measurement in general teleconsulting work in low income countries.  The aim of the present 
work, therefore, was to develop a method for assessing the quality of the teleconsultations 
being conducted in the MSF telemedicine network, and then to examine its feasibility for 
routine adoption. 
 
 
Methods 
The present study required the development of a method to assess quality and then a 
demonstration of its feasibility in practice.  The work was performed in two stages: 
 
(1) development of a quality assessment tool 
(2) demonstration of feasibility in the MSF telemedicine network 
 
Ethics permission was not required, because patient consent to access the data had been 
obtained and the work was a retrospective chart review conducted by the organisation's staff 
in accordance with its research policies. 
 
1. Assessment of quality 
Development of the quality tool 
A questionnaire was developed by a consensus between three experienced telemedicine 
practitioners.  It was based on accepted tools used in previous studies.[8,9]  The final 
questionnaire was evaluated and approved by an independent evaluator.  The final 
questionnaire consisted of 17 questions.  These concerned the information provided by the 
referring doctor, the way that the referral was handled in the telemedicine network, the 
response(s) received from the specialist(s) consulted, and the likely value to the patient, the 
doctor and the organisation. 
 
Definition of quality 
We defined quality in terms of two of the three dimensions of the Donabedian model:  process 
and outcome.  (The structural dimension is not usually relevant in a telemedicine network of 
the sort under discussion).  Thus in assessing the quality of a given teleconsultation, there are 
two principal questions: 
 
(1) was the process by which the response was produced satisfactory?  i.e. what was the 
quality of the teleconsultation process itself? 
 
(2) was the outcome from the teleconsultation useful?  i.e. what was the value of the 
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teleconsultation and to whom? 
 
These questions address separate dimensions of quality, both of concern to network operators.  
That is, the process for producing a response might be satisfactory, but the response itself 
could be useless.  Or the process could be unsatisfactory, but the response might still be 
useful. 
 
Both aspects of quality can best be judged by using a panel of assessors.  This is because any 
evaluation will involve subjective judgements, so a panel of observers is more likely to 
produce an accurate estimate than a single observer.  However, it is not feasible to evaluate 
the quality of every single teleconsultation conducted in the network, so there must be a 
sampling process by which a case is selected (randomly) for assessment at regular intervals.  
This leads to a quality assessment scheme whose main features are summarised in Table 1. 
 
Quality of process 
The quality of the teleconsultation process (qp) can be assessed by the panel members, who 
can make a judgement about various relevant matters.  For example, they can judge whether 
the referrer provided sufficient information, whether the case was sent promptly to an 
appropriate expert, whether an answer was obtained sufficiently quickly to be useful and so 
on.  There are ten questions listed in Table 2 which are relevant to the quality of the process.  
The scoring system is described in Appendix 1. 
 
Value of response 
The value of the response can be assessed in a similar way by the panel members.  There are 
four domains of interest: 
 
1. Value to the patient, vp.  After the patient himself, the person best placed to judge this 
is the referring doctor.  It can also be estimated by senior staff in the organisation 
2. Value to the referring doctor, vr.  The person best able to judge this is the referring 
doctor, but it can also be estimated by senior staff in the organisation 
3. Value to the organisation, vo.  This is probably best judged by senior staff in the 
organisation itself 
4. Value to society as a whole, vs. 
 
The first three values can be assessed by staff with suitable telemedicine experience.  
However, assessing the value to society is much more difficult.  The value to society of 
telemedicine will be partly determined by the health care system in the country concerned 
(mainly, the country where the patient is located), including the degree to which telemedicine 
has been properly integrated into the chain of health care there.  Assessing the value to society 
as a whole is therefore difficult to do on the basis of a single telemedicine case, and is ignored 
in what follows.  It is worth noting that in a humanitarian context (or a not-for-profit 
operation), the value to society will be closely aligned with the value to the organisation. 
 
Direct measurement of value is not straightforward.  In health economics, it is usual to 
measure the cost-effectiveness of the technique in question and to make a comparison (e.g. 
with usual practice) to obtain evidence that it does not represent a waste of resources.  
However, in the context of telemedicine in resource-limited settings, this is not easy to do.  
First, the costs are distorted, because many staff are volunteers and there may also be donor 
support which can be hard to quantify.  Second, the clinical effect of telemedicine may be 
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difficult to document, since patients are commonly lost to follow-up after their initial 
encounter. 
 
How else can the "value" of a teleconsultation episode be measured?  That is, what is the 
value to the interested parties?  Panel members can form a judgement about whether the 
telemedicine response clarified the diagnosis, whether the eventual clinical outcome would be 
beneficial for the patient and so on.  There are nine questions listed in Table 2 which are 
relevant to the value of the response in the domains of interest.  The scoring system is 
described in Appendix 1. 
 
 
2. Demonstration of feasibility 
To demonstrate the feasibility of the proposed approach, a panel of 12 experts were invited to 
answer the 17 questions about randomly-selected telemedicine cases, see Table 2.  Cases were 
chosen at random for a 9-month period.  The process was: 
 
(1) the system automatically selected a past case for review at the beginning of each 
month.  The case was chosen randomly from those referred 4-8 weeks previously.  If 
there were fewer than four cases in the period of interest, no case was selected.  (The 
average case submission rate during the period in question was approximately one 
case per day.) 
(2) the members of the quality assessment panel were notified by email that a case had 
been chosen for review.  The panel comprised mainly senior doctors with previous 
MSF field experience;  there were three other healthcare professionals with 
telemedicine experience. 
(3) panel members logged in to the telemedicine system, viewed the information about the 
chosen case and answered the questions about the case.  The questions had simple, 
multiple-choice answers which were presented in a drop-down box for ease of 
selection.  Panel members could not view the answers from any other panel member 
until they had provided their own. 
(4) when at least one set of answers had been provided, the system calculated the quality 
scores for the case.  The four quality scores were values in the range 0-10. 
 
Process stability 
A control chart was used to examine the stability of the monthly quality scores.  Control 
charts can be plotted for each of the four quality indices, but for simplicity, a Grand Quality 
Score (GQS) for each case was calculated from the panel's quality and value scores as: 
 
G = Qp + Vp + Vr + Vo  
 
That is, the GQS represents an equi-weighted summation of the four constituent indices.  The 
GQS was transformed to lie in the range 0-10 (0=worst, 10=best). 
 
The cusum chart is a well-established and powerful method for identifying changes in a 
process average.  The chart plots the cumulative difference between the recorded values and a 
target value, which is often chosen to be the process average.  The GQS values were plotted 
as a cusum, using the grand mean as the reference value. 
 
Note that there are two important assumptions underlying the use of control charts:  the 
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measurement that is used to monitor the process is distributed according to a normal 
distribution;  it was not necessary to transform the data in the present case.  Also, the 
measurements are assumed to be independent of each other. 
 
 
Results 
The panel assessed randomly-selected cases starting in July 2013.  At least 4 responses were 
received for each case.  The median panel score for process quality was 8.0 (IQR 7.3,8.7) 
across the nine cases.  The lowest score awarded for process quality by an individual panel 
member in any case was 4.7 and the highest was 9.0.  The median values in each case are 
shown in Figure 1.  There was good agreement between panel members about process quality, 
i.e. relatively small IQRs for each case. 
 
The median panel score for value to the patient was 8.9 (IQR 7.8,8.9).  The lowest score 
awarded for value to the patient was 3.3 and the highest was 10.  The median values in each 
case are shown in Figure 2.  The agreement between panel members was less good than for 
process quality. 
 
The median panel score for value to the doctor was 9.1 (IQR 8.6, 9.5).  The lowest score 
awarded for value to the doctor was 5.7 and the highest was 10.0.  The median values in each 
case are shown in Figure 3.  The agreement between panel members was better than for value 
to the patient. 
 
The median panel score for value to the organisation was 8.9 (IQR 7.2, 10.0).  The lowest 
score awarded for value to the organisation was 5.6 and the highest was 10.0.  The median 
values in each case are shown in Figure 4.  The agreement between panel members was less 
good than for value to the doctor. 
 
The median panel GQS was 8.6 (IQR 7.6, 9.2).  The lowest individual GQS was 6.1 and the 
highest was 9.8  The median values in each case are shown in Figure 5.  The cusum is shown 
in Figure 6.  There was no evidence that the process was out of control, i.e. with steadily 
increasing or steadily decreasing values.  In fact, over the epoch studied, the cusum was 
essentially zero at the end, while deviations no larger than +12% occurred over the study 
period. 
 
 
Discussion 
We have developed a quality assessment scheme for a store-and-forward telemedicine 
network and demonstrated its feasibility in a real-life clinical setting.  There appear to be no 
previous reports of similar work. 
 
Relation to other evidence 
Previous work on assessment of quality in telemedicine networks has often focused on user 
satisfaction (e.g. Von Wanenheim et al[10]), which is a related, but different, concept.  Most 
previous quality studies have been retrospective reviews, such as that conducted by Mahnke 
et al.[11]  There have been few attempts to measure the value to the clinician, although Chan 
et al investigated this in a real-time teleconsultation network in a high-income country.[12] 
 
Methodological issues 
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The proposed method was trialled in a real-life telemedicine network, where it was shown to 
be feasible and appeared to produce useful results.  It thus appears suitable for routine 
adoption.  Implicit in the methodology are a number of design decisions. 
 
1. Questionnaire.  The size of the questionnaire is likely to influence the number of 
responses from the panel.  The right balance has to be struck between asking too few 
questions and too many.  On one hand, the more questions that are asked, the better the 
situation can be assessed;  but on the other hand, too many questions will discourage 
the observers from responding which will make the system less sustainable.  In 
practice 10-20 questions seems to be a reasonable number. 
 
2. Monitoring and stability.  Which index (process quality, and the three value domains) 
is most appropriate for long-term monitoring, in order to measure network 
performance?  Are all four indices of equal importance, or should some be more 
heavily weighted than others?  Should they be monitored collectively, rather than 
individually?  This requires further work. 
 
3. Sampling.  How often should cases be sampled and monitoring be done?  On one 
hand, more frequent sampling will allow closer performance monitoring;  on the other 
hand, it is likely to lead to "observer fatigue".  In practice, we suggest that random 
sampling of one case per month is about right. 
 
4. Size of panel.  How many panel members should give an opinion?  The more 
members there are, the more likely there is to be disagreement between them;  on the 
other hand, the more there are, the better the estimate of the underlying value.  In 
practice, we suggest that 5-10 panel members is about right. 
 
Quality assurance 
Routine measurement of quality on randomly-selected cases is only one part of the whole 
evaluation process and will form one element of an overall quality assurance programme for 
the telemedicine network concerned.  Other elements may include obtaining other points of 
view and follow up reports to assess long-term outcomes concerning the cases and the 
benefits of the expertise. 
 
Limitations 
The present work has certain limitations.  For example, before it could be used routinely, the 
quality-assessment methodology would require validation.  However, it is difficult to validate 
the proposed indices independently, especially in the context of a telemedicine network 
operated by a humanitarian organisation.  Ideally, they should be evidence-based, and of 
demonstrated validity and reliability.[13]  Further work is required to find out whether this is 
possible, since the practical problem of the lack of an obvious gold standard needs to be 
overcome.  Validation may therefore require psychometric methods.[14] 
 
Industrial process control is normally done using an absolute standard as the reference.  In the 
present work, a relative reference value was employed.  That is, it represents an assessment of 
relative quality, which pragmatically, is probably better than no assessment at all.  Again, 
further work is required to find out whether absolute reference standards can be developed. 
 
Finally, the quality of this evaluation relies on the information available for assessing the case.  
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Sampling a case at a particular time may be problematic if there is insufficient feedback on 
follow up.  It also relies on the expertise and experience of the assessor panel.  The panel 
members must be selected carefully and it is important that they have no conflict of interest.  
This is why is it may be better to use independent volunteers, rather than senior staff from the 
organisation running the network. 
 
Interpretation 
The present method provides estimates of the value to the main parties concerned in a 
teleconsultation, together with an estimate of the quality of the teleconsultation process itself. 
This is important information for those responsible for the operation of the network.  To the 
best of our knowledge there has been no information published previously about the quality of 
general teleconsultations in a store-and-forward network.  Yet, if telemedicine is considered 
sufficiently mature that it can enter routine service, there is an ethical imperative to ensure 
that it is employed in a cost-effective manner.  The method described here provides an 
instrument for monitoring quality and will form part of the toolset used by the operators of the 
MSF telemedicine network in future. 
 
Once a method for assessing quality is available, application of industrial process control 
methodology allows the stability of the network to be monitored.  Again, this is important if 
network operators are to be reassured that quality is not in slow decline.  The information may 
also be valuable in improving the performance of healthcare staff in low-resource settings, 
which is known to be a difficult problem.[15] 
 
The techniques presented in this paper are of wide application.  They could potentially be 
used in non-telemedicine consultations (i.e. conventional, face-to-face consulting), and in 
industrialised countries as well as resource-limited settings. 
 
 
Conclusions 
A method for assessing the quality of the teleconsultations in a store-and-forward 
telemedicine network is proposed.  It provides estimates of the quality of the process and the 
value of the consultation to the main parties involved.  A trial of the method showed that it 
was feasible and that the process in the network studied was stable.  The method appears to 
give useful results.  It seems desirable to implement it in other telemedicine projects where it 
can contribute to the evaluation of practice, something that is necessary in all medical services 
provided. 
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Table 1.  Main features of the quality assessment scheme 
Sampling of process output One case per month is selected at random 
Panel of assessors Senior staff (n=12) with experience in the field (mainly 
doctors) 
Evaluation -- individual scores Each panel member responds (independently) to a set of 
questions, from which the following can be computed: 
process quality (qp) and value scores (vp, vr, vo) 
Evaluation -- panel scores Aggregated scores are then calculated to indicate the 
panel's overall assessment of process quality (Qp) and 
value (Vp, Vr, Vo), based on the median panel scores 
Evaluation -- composite score Finally, a composite score is calculated to reflect the 
panel's overall assessment of quality (based on the 
process quality and value scores) 
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Table 2.  Quality assessment questions 
Question Response choices Quality 
of the 
process, 
QP 
Value to 
the 
patient, 
Vp 
Value to 
the 
referring 
doctor, 
Vr 
Value to 
the 
organisat
ion, Vo 
Value 
to 
society, 
Vs 
1. Was the question asked by the referring doctor clear? Yes/Perhaps/No/Don't know X     
2. Did the referrer provide sufficient information? Yes/Perhaps/No/Don't know X     
3. Were any images provided? Yes/No      
4. ... if YES, were the images adequate? Yes/Perhaps/No/Don't know X     
5. ... if NO, would some images have helped? Yes/Perhaps/No/Don't know X     
6. Overall, could the referral have been improved? Yes/Perhaps/No/Don't know X     
7. Was the case sent to an appropriate expert? Yes/Perhaps/No/Don't know X  X   
8. Was the answer provided sufficiently quickly? Yes/Perhaps/No/Don't know X  X   
9. Was the answer(s) well-adapted for the local 
environment? 
Yes/Perhaps/No/Don't know X  X   
10. Overall, could the answer have been improved? Yes/Perhaps/No/Don't know X  X   
11. Did the telemedicine advice clarify the diagnosis for 
the doctor and patient? 
Yes/Perhaps/No/Don't know  X X   
12. Did the suggested action help the doctor manage the 
patient? 
Yes/Perhaps/No/Don't know  X X   
13. Do you think that the eventual clinical outcome will 
be beneficial for the patient? 
Yes/Perhaps/No/Don't know  X  X  
14. Was the consultation useful for the doctors Yes/Perhaps/No/Don't know   X X  
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concerned? 
15. Could the allocation/coordination have been 
improved? 
Yes/Perhaps/No/Don't know X     
16. Was the consultation good from the organization's 
point of view? 
Yes/Perhaps/No/Don't know    X X 
17 Do you have any comments about this case? (Free text)      
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Appendix.  Scoring of questions 
 
The questions set out in Table 2 are presented as multiple choices for simplicity.  
Scoring for most questions -- those in which an affirmative response indicated 
satisfaction with the item being considered -- was:  No=1, Perhaps=2, Yes=3.  However, 
some questions required reversed scoring, where an affirmative indicated 
dissatisfaction:  Yes=1, Perhaps=2, No=3. 
 
Don't-know responses were coded as zeroes, i.e. they were treated in the same way as 
missing values.  That is, no distinction was made in the present work between missing 
values and don't-know responses.  These may represent cases where assessors 
experienced particular difficulty in forming a judgement. 
 
Individual scores 
Scores were first calculated for each individual panel member, as follows.  The process 
quality score from a panel member who had assessed a particular case was calculated 
as: 
 
qp = s1 + s2 + s4 + s5 + s6 + s7 + s8 + s9 + s10 + s15 
 
where the response elements, s1, s2 ... refer to the responses in Table 2, reverse-scored 
where appropriate. 
 
The value scores from a given panel member were calculated as: 
 
vp = s11 + s12 + s13 
 
vr = s7 + s8 + s9 + s10 +s11 + s12 + s14 
 
vo = s13 + s14 + s16 
 
In the above calculations, the response elements for a given panel member were 
aggregated by simple summation.  That is, the constituent responses for the questions 
being used in a particular score were equi-weighted. 
 
For convenience, the values qp, vp, vr and vo were transformed to lie in the range 0-10 
(0=worst, 10=best). 
 
Panel scores 
The individual panel member scores were aggregated to produce a panel mean, which 
represents the best estimate of the underlying true value pertaining to the case in 
question.  In the absence of a compelling reason to use a more complex scheme, the 
individual scores were equally weighted, i.e. this amounts to placing similar value on 
the judgement of all members of the panel.  For example, the panel's best estimate of 
process quality was: 
 
Qp = (q1 + q2 + ... + qi) / n 
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where Qp is the panel process quality score, and q1, q2 ... are the individual scores  for 
process quality from the n panel members. 
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Figure 1.  Median scores for process quality (0=worst; 10=best).  The error bars 
indicate the 25th and 75th percentiles. 
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Figure 2.  Median scores for value to patient (0=worst; 10=best).  The error bars 
indicate the 25th and 75th percentiles. 
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Figure 3.  Median scores for value to referrer (0=worst; 10=best).  The error bars 
indicate the 25th and 75th percentiles. 
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Figure 4.  Median scores for value to the organisation (0=worst; 10=best).  The error 
bars indicate the 25th and 75th percentiles. 
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Figure 5.  Median scores for general quality (0=worst; 10=best).  The error bars indicate 
the 25th and 75th percentiles. 
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Figure 6.  Cusum of General Quality Score. 
 
 
